Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States

Rheumatoid Arthritis

Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial

Ann Rheum Dis

van Mulligen E, Bour SS, Goossens LMA, de Jong PHP, Rutten-van Mölken M, van der Helm-van Mil A

doi: 10.1136/ard-2024-226286

Allergic DiseasesFurther Publications Immunology

Human papillomavirus infection is associated with increased risk of new-onset hidradenitis suppurativa: a population-based cohort study

J Am Acad Dermatol

Gau SY, Lo SW, Hsu C, Chen SJ, Zuberbier T, Chang HC

doi: 10.1016/j.jaad.2024.10.055

Osteoporosis

Ten-year follow-up of fracture risk in a systematic population-based screening program: the risk-stratified osteoporosis strategy evaluation (ROSE) randomised trial

EClinicalMedicine

Petersen TG, Abrahamsen B, Høiberg M, Rothmann MJ, Holmberg T, Gram J, Bech M, Åkesson KE, Javaid MK, Hermann AP, Rubin KH

doi: 10.1016/j.eclinm.2024.102584

Further Publications DermatologyFurther Publications Immunology

Human Papillomavirus Vaccination and Actinic Keratosis Burden: The VAXAK Randomized Clinical Trial

JAMA Dermatol

Wenande E, Hastrup A, Wiegell S, Philipsen PA, Thomsen NB, Demehri S, Kjaer SK, Haedersdal M

doi: 10.1001/jamadermatol.2025.0531

Further Publications Immunology

Higher hospital volume reduces early failure rates in single-stage revision TKR for infection: An analysis of the United Kingdom National Joint Registry and National Administrative Databases

Knee Surg Sports Traumatol Arthrosc

Matthews AH, Gray WK, Evans JP, Knight R, Evans JT, Lamb SE, Briggs T, Porteous A, Sabah SA, Alvand A, Price A, Toms AD

doi: 10.1002/ksa.12578

Rheumatoid Arthritis

Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study

Ann Rheum Dis

Rayens E, Sy LS, Qian L, Wu J, Ackerson BK, Luo Y, Cheng Y, Lin AT, Solano Z, De Jesus J, Amundsen B, Florea A, Ku JH, Chmielewski-Yee E, Oraichi D, Seifert H, Yun H, Tseng HF

doi: 10.1016/j.ard.2025.01.045

Further Publications Immunology

Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

Pediatr Allergy Immunol

Ares-Gómez S, Mallah N, Pardo-Seco J, Malvar-Pintos A, Pérez-Martínez O, Otero-Barrós MT, Súarez-Gaiche N, Santiago-Pérez MI, González-Pérez JM, López-Pérez LR, Rosón B, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F

doi: 10.1111/pai.14131

Psoriatic Arthritis

Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases

Adv Ther

Mease PJ, Papademetriou E, Potluri R, Agarwal E, Cappelleri JC, Ling YL

doi: 10.1007/s12325-024-02904-y

Osteoporosis

Long Dosing Intervals of Parenteral Antiosteoporosis Medications and the Decrease in Societal Fracture Risk: A 11-Year Nationwide Population-Based Cohort Study

Mayo Clin Proc

Fu SH, Yen HK, Yang RS, Hung CC, Lin JW, Lee MT, Chen HM, Wu CH, Hsu CC, Li CY, Groot OQ, Wang CY

doi: 10.1016/j.mayocp.2024.05.002

Related content